Other Development Expenses. Alexion shall bear seventy percent (70%), and XOMA shall bear thirty percent (30%), of all Development Expenses incurred in conducting each activity under a Development Plan that is not a First-Time Pre-Clinical Development Activity.
Appears in 5 contracts
Samples: Co Development and Co Commercialization Agreement, Co Development and Co Commercialization Agreement (Alexion Pharmaceuticals Inc), Co Development and Co Commercialization Agreement (Alexion Pharmaceuticals Inc)
